IP Verse

Wittkopp patent opposition analysis

The comprehensive analysis of Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wittkopp

Stay updated with the latest patent oppositions filed by Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKMay 5, 2026SYNTHON
EP4426307
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026HAMM & WITTKOPP
EP3449911
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026HAMM & WITTKOPP
EP3908276
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMar 11, 2026SYNTHON
EP3411021
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 16, 2026ALFRED E TIEFENBACHER
EP3435996
Methods Of Treatment Of Cholestatic DiseasesGENFITJan 29, 2026HAMM & WITTKOPP
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 29, 2026ALFRED E TIEFENBACHER
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 23, 2026POLPHARMA
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026HAMM & WITTKOPP
EP3518975
Formulation For Inhibiting Formation Of 5-Ht 2B Agonists And Methods Of Using SameZOGENIXJan 6, 2026ALFRED E TIEFENBACHER

Top clients of Wittkopp

Top companies who are the clients of Wittkopp

CompanyTotal
HAMM & WITTKOPP110
STADA ARZNEIMITTEL79
ALFRED E TIEFENBACHER50
SYNTHON26
BETAPHARM ARZNEIMITTEL11
POLPHARMA10
WITTKOPP10
ALVOGEN IPCO4
G L PHARMA4
TEVA PHARMACEUTICALS4